Role of a nonsteroidal anti-inflammatory agent, ibuprofen, in coronary revascularization after acute myocardial infarction
- 35 Downloads
The efficacy of using a nonsteroidal anti-inflammatory agent such as ibuprofen for the salvage of ischemic and reperfused myocardium was investigated by examining its ability to improve global and regional functions as well as to preserve high-energy phosphate compounds and inhibit creatine kinase release from an isolated in-situ pig heart subjected to 1 h of normothermic regional ischemia followed by 1 h of global hypothermic arrest and 1 h of normothermic reperfusion. Preperfusion of the heart for 15 min prior to ischemic insult with 50 μM ibuprofen failed to mitigate the myocardial reperfusion injury. Ibuprofen, however, functioned as an anti-inflammatory agent, as judged by its ability to inhibit the influx of indium-111-labeled polymorphonuclear leukocytes and chromium-51 (51Cr)-labeled platelets into the ischemic and reperfused heart. It also blocked the cyclooxygenase pathway, as evidenced by the significant reduction of 6-keto-prostaglandin F1α and thromboxane B2 concentrations in the perfusate. Inhibition of cyclooxygenase resulted in increased accumulation of nonesterified fatty acids, particularly arachidonic acid, in the heart. These results suggest that although ibuprofen can inhibit polymorphonuclear leukocyte and platelet influx into the ischemic and reperfused heart, it causes further damage to the already ischemic heart by reducing prostacyclin concentration and increasing free fatty acids in the heart.
Key wordsischemia reperfusioninjury ibuprofen prostaglandins neutrophils
Unable to display preview. Download preview PDF.
- 3.Bednar M, Smith B, Mullane K (1984) Nafazatrom-induced inhibition of neutrophil function mediates salvage of ischemia myocardium. Fed Proc 43:389Google Scholar
- 9.Chesbro JH, Fuster V, Elveback LR, Clements IP, Smith HC, Holmes DR, Bardsley WT, Pluth JR, Wallace RB, Puga FJ, Orzsulak TA, Piehler JM, Danielson GK, Schaff HV, Frye RL (1984) Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med 310:209–214PubMedGoogle Scholar
- 12.Cordis GA, Prasad MR, Otani H, Engelman RM, Das DK (1987) Measurement of polyunsaturated fatty acids and acyl chain composition of myocardial lipids by high performance liquid chromatography. Chromatographia (in press)Google Scholar
- 14.Das DK (1986) Modulation of deacylation-reacylation pathway of phospholipid metabolism and turnover during reperfusion of ischemic myocardium. In: Freyez L, Dreyfus H, Massarelli R, Gatt S (eds) Enzymes of lipid metabolism II; Plenum Publishing Corp, New York, pp 93–98Google Scholar
- 18.Engler R, Schmid-Schonbein GW, Paveler LR (1981) Role of leukocyte-capillary plugging in preventing myocardial reperfusion. Circulation 64 (suppl IV):138Google Scholar
- 20.Fantone J, Ward P (1982) Role of oxygen-derived free radical and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 107:397–418Google Scholar
- 29.Leinberger H, Suehiro GT, McNamara JJ (1979) Myocardial platelet trapping after coronary ligation in primates. J Surg Res 17:3–40Google Scholar
- 31.Mitsos SE, Askew TE, Fantone JC, Kunkel SL, Abrams GD, Schork A, Luechesi BR (1986) Protective effects of N-z-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil depletion in dog: evidence for the role of intracellular-derived free radicals. Circulation 73:1077–1086PubMedGoogle Scholar
- 37.Packham MA, Mustard JF (1980) Pharmacology of platelet-affecting drugs. Circulation G20 (Suppl V):V26-V41Google Scholar
- 43.Tillmanns H, Kubler (1984) What happens in the microcirculation? In: Hearsc DJ, Yellon DM (eds) Therapeutic approaches to myocardial infarct size limitation. Raven Press, New York, pp 107–124Google Scholar